SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015426
Filing Date
2023-09-05
Accepted
2023-09-05 08:35:11
Documents
14
Period of Report
2023-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20230830x8k.htm   iXBRL 8-K 50567
2 EX-10.1 xlo-20230830xex10d1.htm EX-10.1 93575
3 EX-99.1 xlo-20230830xex99d1.htm EX-99.1 17885
  Complete submission text file 0001558370-23-015426.txt   315150

Data Files

Seq Description Document Type Size
4 EX-101.SCH xlo-20230830.xsd EX-101.SCH 3112
5 EX-101.LAB xlo-20230830_lab.xml EX-101.LAB 16576
6 EX-101.PRE xlo-20230830_pre.xml EX-101.PRE 10706
8 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20230830x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 231234222
SIC: 2834 Pharmaceutical Preparations